Regeneration of Capto Core 700 resin through high throughput and laboratory scale studies and impact on production of a SARS-CoV-2 vaccine candidate.

Saved in:
Bibliographic Details
Title: Regeneration of Capto Core 700 resin through high throughput and laboratory scale studies and impact on production of a SARS-CoV-2 vaccine candidate.
Authors: Konstantinidis S; Vaccine Process Research & Development, Merck & Co., Inc., Rahway, New Jersey, USA., Reinhart SR; Vaccine Process Research & Development, Merck & Co., Inc., Rahway, New Jersey, USA., Castagna C; Vaccine Process Research & Development, Merck & Co., Inc., Rahway, New Jersey, USA., Poplyk MR; Vaccine Process Research & Development, Merck & Co., Inc., Rahway, New Jersey, USA., Rustandi RR; Vaccine Analytical Research & Development, Merck & Co., Inc., Rahway, New Jersey, USA., Flor KL; Investigative Pathology, MRL, Merck & Co., Inc., Rahway, New Jersey, USA., Acevedo-Skrip J; Vaccine Analytical Research & Development, Merck & Co., Inc., Rahway, New Jersey, USA., Thompson R; Vaccine Analytical Research & Development, Merck & Co., Inc., Rahway, New Jersey, USA., Wang CJ; Vaccine Analytical Research & Development, Merck & Co., Inc., Rahway, New Jersey, USA., Wang SC; Vaccine Process Research & Development, Merck & Co., Inc., Rahway, New Jersey, USA., Winters MA; Vaccine Process Research & Development, Merck & Co., Inc., Rahway, New Jersey, USA.
Source: Biotechnology journal [Biotechnol J] 2022 Oct; Vol. 17 (10), pp. e2200191. Date of Electronic Publication: 2022 Jul 28.
Publication Type: Journal Article
Journal Info: Publisher: Wiley-VCH Verlag Country of Publication: Germany NLM ID: 101265833 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1860-7314 (Electronic) Linking ISSN: 18606768 NLM ISO Abbreviation: Biotechnol J Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1860-7314
DOI:10.1002/biot.202200191